La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Waystar Holding a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Waystar Holding..

Waystar Holding (NASDAQ:WAY) Azioni, Catena delle Opzioni

Waystar Holding

Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in better transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for our solutions extends throughout the United States and includes Puerto Rico and other US Territories.

Waystar Holding Corp

Wayne Savings Bancshares Inc Com

Wave Sync Corp

WAYFAIR CL A ORD

Wayfair Inc

WaykiChain

WAYLAND GROUP CORP ORD by Wayland Group Corp.

Wayland Group Corp

WAYPOINT BIOMED HLDGS INC by WayPoint Biomedical Holdings, Inc.

Waypoint Biomedical Holdings Inc

Waypoint REIT Ltd

Information Servs Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/III#NASDAQ">III</a>) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.06 by 16.67 percent. This is a 54.55 percent decrease over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $61.28 million which beat the analyst consensus estimate of $60.50 million by 1.28 percent. This is a 14.62 percent decrease over sales of $71.77 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

News

Information Servs Gr Q3 Adj $0.05 Misses $0.06 Estimate, Sales $61.28M Beat $60.50M Estimate

AudioEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEYE#NASDAQ">AEYE</a>) reported quarterly earnings of $0.16 per share. This is a 700 percent increase over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $8.925 million which beat the analyst consensus estimate of $8.905 million by 0.22 percent. This is a 13.87 percent increase over sales of $7.838 million the same period last year.

AEYE

AudioEye Q3 2024 Adj. EPS $0.16 Up From $0.02 YoY, Sales $8.925M Beat $8.905M Estimate

WIIM

ADEA

Adeia shares are trading lower after the company reported worse-than-expected Q3 financial results.

MRVI

Maravai LifeSciences shares are trading lower after the company reported worse-than-expected Q3 financial results and cut its FY24 sales guidance.

Management

AFRM

Affirm Holdings Appointed Rob O'Hare As CFO

Protagonist Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTGX#NASDAQ">PTGX</a>) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.63) by 14.29 percent. This is a 6.9 percent increase over losses of $(0.58) per share from the same period last year. The company reported quarterly sales of $4.67 million which beat the analyst consensus estimate of $2.07 million by 125.74 percent.

PTGX

Protagonist Therapeutics Q3 EPS $(0.54) Beats $(0.63) Estimate, Sales $4.67M Beat $2.07M Estimate

Backblaze (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLZE#NASDAQ">BLZE</a>) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.24) by 58.33 percent. This is a 52.38 percent increase over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $32.59 million which beat the analyst consensus estimate of $32.44 million by 0.46 percent. This is a 28.82 percent increase over sales of $25.30 million the same period last year.

BLZE

Backblaze Q3 Adj $(0.10) Beats $(0.24) Estimate, Sales $32.59M Beat $32.44M Estimate

WBTN

Webtoon entertainment shares are trading higher after the company reported a year-over-year increase in Q3 adjusted EPS results and better-than-expected Q3 revenue results.

Portman Ridge Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTMN#NASDAQ">PTMN</a>) reported quarterly earnings of $0.63 per share which missed the analyst consensus estimate of $0.68 by 7.35 percent. The company reported quarterly sales of $15.177 million which missed the analyst consensus estimate of $16.256 million by 6.64 percent. This is a 18.29 percent decrease over sales of $18.574 million the same period last year.

PTMN

Portman Ridge Finance Q3 2024 GAAP EPS $0.63 Misses $0.68 Estimate, Sales $15.177M Miss $16.256M Estimate

Silvercorp Metals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SVM#AMEX">SVM</a>) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.08 by 12.5 percent. The company reported quarterly sales of $68.00 million which beat the analyst consensus estimate of $65.04 million by 4.55 percent. This is a 25.94 percent increase over sales of $53.99 million the same period last year.

Silvercorp Metals Q2 2025 Adj EPS $0.07 Misses $0.08 Estimate, Sales $68.00M Beat $65.04M Estimate

Guidance

CNHI Says The Company's Forecast Of Continued Weak Industry Retail Demand In Both The Agriculture And Construction Equipment Markets, Coupled With Elevated Dealer Inventories Is Requiring Lower Production Levels; Sees 2024 Adj. EPS $1.05-$1.15 (Prior $1.30-$1.40)

Funko (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FNKO#NASDAQ">FNKO</a>) lowers FY2024 sales outlook from $1.05 billion-1.10 billion to $1.04 billion-1.05 billion.

FNKO

Funko Lowers FY2024 Sales Guidance from $1.05B-1.10B to $1.04B-1.05B  VS Est.1.07B

Wheaton Precious Metals Expects Estimated Attributable Production In 2024 To Be 325K-370K Ounces Of Gold; 18.5M-20.5M Ounces Of Silver.

Brilliant Earth Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRLT#NASDAQ">BRLT</a>) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $0.00 by Infinity percent. The company reported quarterly sales of $99.873 million which missed the analyst consensus estimate of $100.250 million by 0.38 percent. This is a 12.51 percent decrease over sales of $114.154 million the same period last year.

BRLT

Brilliant Earth Group Q3 2024 Adj. EPS $0.02 Beats $0.00 Estimate, Sales $99.873M Miss $100.250M Estimate

AvePoint (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVPT#NASDAQ">AVPT</a>) raises FY2024 sales outlook from $320.20 million-324.20 million to $327.80 million-329.80 million.

AVPT

AvePoint Raises FY2024 Sales Guidance from $320.20M-324.20M to $327.80M-329.80M

Buybacks

EOG Resources Approves $5B Increase In Share Repurchase Authorization

AvePoint (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVPT#NASDAQ">AVPT</a>) sees Q4 sales of $86.500 million-88.500 million vs $86.80 million estimate.

AvePoint Sees Q4 Sales $86.500M-88.500M vs $86.80M Est

Pebblebrook Hotel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEB#NYSE">PEB</a>) lowers FY2024 FFO guidance from $1.59-1.67 to $1.57-1.60 vs $1.61 analyst estimate..

Pebblebrook Hotel Lowers FY2024 FFO Guidance from $1.59-1.67 to $1.57-1.60 vs $1.61 Est

Heritage Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HGBL#NASDAQ">HGBL</a>) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.06 by 50 percent. This is a 40 percent decrease over earnings of $0.05 per share from the same period last year. The company reported quarterly sales of $10.41 million which missed the analyst consensus estimate of $13.37 million by 22.14 percent. This is a 33.06 percent decrease over sales of $15.55 million the same period last year.

HGBL

Heritage Glb Q3 EPS $0.03 Misses $0.06 Estimate, Sales $10.41M Miss $13.37M Estimate

Pebblebrook Hotel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEB#NYSE">PEB</a>) is looking for Q4 FFO of $0.08-0.11 vs $0.19 analyst estimate..

Pebblebrook Hotel Sees Q4 FFO $0.08-0.11 vs $0.19 Est

Earlier this year, healthcare payments technology provider, Waystar went public to a tepid debut. The market seems to have improved now and the stock has been climbing since.

IPOs 2024: Waystar Delivers A Successful IPO

Bank of America Securities analyst Allen Lutz reiterated a Buy rating on Waystar Holding Corp. (WAY – Research Report) today and set a price target...

Waystar Holding Corp Poised for Growth Amidst RCM Vendor Shifts Post-Cyberattack

Global IPO Activity Picking Up But Continues To Lag Other Post-COVID Years

In a report released today, Stephanie Davis from Barclays maintained a Buy rating on Waystar Holding Corp. (WAY – Research Report), with a price ta...

Barclays Remains a Buy on Waystar Holding Corp. (WAY)

Sees FY24 revenue $926M-$934M, consensus $912.19M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ...

Waystar sees FY24 adjusted EPS 30c-32c, consensus 27c

Waystar Holding Corp. ( ($WAY) ) has released its Q3 earnings. Here is a breakdown of the information Waystar Holding Corp. presented to its invest...

Waystar Holding Corp. Reports Strong Q3 2024 Performance

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on Waystar Holding Corp. (WAY – Research Report) today and set a price target o...

Waystar Holding Corp. (WAY) Receives a Buy from Evercore ISI

Canaccord raised the firm's price target on Waystar (WAY) to $36 from $30 and keeps a Buy rating on the shares. The firm said following a strong 3Q...

Waystar price target raised to $36 from $30 at Canaccord

RBC Capital raised the firm's price target on Waystar (WAY) to $34 from $31 and keeps an Outperform rating on the shares. The company's Q3 revenue ...

Waystar price target raised to $34 from $31 at RBC Capital

Waystar Non-GAAP EPS of $0.14 misses by $0.01, revenue of $240.1M beats by $10.36M

ALAB

BTSG

IBTA

LINE

RBRK

RDDT

Fintech

Press Releases

Waystar announces term loan repricing and credit rating upgrades from Fitch, Moody's, and S&P Global

Waystar awarded top-ranking healthcare payment software platform from Black Book

Waystar to Announce Second Quarter 2024 Financial Results on August 7, 2024

Waystar Reports Second Quarter 2024 Results

Waystar CEO to Speak at Canaccord Genuity Growth Conference

Waystar Wins Stevie® Awards for Company of the Year and AI Solutions in Healthcare

New Research from Waystar and Modern Healthcare Reveals AI's Transformative Impact on Healthcare Payments

Legal

Kaskela Law LLC Announces Shareholder Investigation of Waystar Holding Corp. (NASDAQ: WAY) and Encourages Investors to Contact the Firm

Waystar to Announce Third Quarter 2024 Financial Results on November 6, 2024

Waystar Reports Third Quarter 2024 Results

Firefly Neuroscience, Inc. - Common Stock

Firefly Neuroscience

American Well Corporation Class A Common Stock

American Well

Bullfrog AI Holdings, Inc. - Common Stock

Bullfrog AI Hldgs

CareCloud

Certara

Definitive Healthcare Corp. - Class A Common Stock

Definitive Healthcare

Doximity

DarioHealth

Evolent Health

Forian

GoodRx Holdings, Inc. - Class A Common Stock

GoodRx Holdings

Health Catalyst

HealthStream

icad

LifeMD

MultiPlan Corporation Class A Common Stock

MultiPlan

OptimizeRx

Phreesia

Pheton Holdings Ltd - Class A Ordinary Shares

Pheton Holdings

Schrodinger

Simulations Plus

Sophia Genetics

TruBridge

Teladoc Health

Veeva Systems

Canaccord Genuity

RBC Capital

Goldman Sachs

Evercore ISI Group

B of A Securities

Waystar Holding shares are trading higher after the company reported better-than-expected Q3 financial results and issued FY24 guidance above estimates.

Comments

Waystar Holding

Waystar Holding (WAY) Opzioni

Waystar Holding (NASDAQ:WAY) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO